Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantation.
Herve
P
P
Bone Marrow Transplant Unit of Besançon, France.
Bordigoni
P
P
Cahn
J Y
JY
Flesch
M
M
Tiberghien
P
P
Racadot
E
E
Milpied
N
N
Bergerat
J P
JP
Plouvier
E
E
Roche
C
C
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D006086:Graft vs Host Disease / Q000628:therapy*; D006648:Histocompatibility; D006801:Humans; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha